UPDATE 1-Roche's Tecentriq wins fast FDA review in tough-to-treat breast cancer
November 13, 2018 at 02:09 AM EST
* Roche aiming to be first-to-market in niche areas (Adds comment from company, details about trial)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|